| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
10,674 |
9,949 |
$375K |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
3,636 |
3,275 |
$180K |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
1,205 |
1,142 |
$122K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
395 |
323 |
$43K |
| 80053 |
Comprehensive metabolic panel |
4,906 |
4,277 |
$39K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
4,692 |
4,056 |
$29K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
1,045 |
973 |
$21K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
466 |
452 |
$18K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
440 |
413 |
$18K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
718 |
687 |
$10K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
230 |
224 |
$10K |
| 81001 |
|
1,972 |
1,750 |
$6K |
| 87631 |
|
70 |
61 |
$5K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
77 |
77 |
$3K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
42 |
41 |
$3K |
| 71045 |
Radiologic examination, chest; single view |
710 |
628 |
$2K |
| 80061 |
Lipid panel |
135 |
131 |
$2K |
| 71046 |
Radiologic examination, chest; 2 views |
278 |
247 |
$2K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
391 |
319 |
$2K |
| 87081 |
|
168 |
162 |
$1K |
| 84443 |
Thyroid stimulating hormone (TSH) |
126 |
105 |
$1K |
| 83735 |
|
273 |
218 |
$1K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
47 |
41 |
$1K |
| 85027 |
|
333 |
282 |
$1K |
| 82607 |
|
49 |
46 |
$810.12 |
| 70450 |
Computed tomography, head or brain; without contrast material |
13 |
12 |
$778.61 |
| 83880 |
|
84 |
58 |
$704.33 |
| 84484 |
|
137 |
100 |
$585.71 |
| 80048 |
Basic metabolic panel (calcium, ionized) |
150 |
114 |
$517.86 |
| 84439 |
|
48 |
45 |
$472.63 |
| 85610 |
|
175 |
135 |
$349.46 |
| 83605 |
|
76 |
52 |
$336.30 |
| 82553 |
|
14 |
13 |
$291.85 |
| 82550 |
|
30 |
25 |
$251.11 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
252 |
225 |
$218.96 |
| J7030 |
Infusion, normal saline solution , 1000 cc |
113 |
87 |
$178.93 |
| 85730 |
|
175 |
135 |
$176.80 |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
12 |
12 |
$142.20 |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
15 |
14 |
$111.15 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
2,738 |
2,332 |
$97.64 |
| 74018 |
|
17 |
14 |
$79.38 |
| 83690 |
|
20 |
15 |
$56.56 |
| 82150 |
|
18 |
14 |
$56.49 |
| 81025 |
|
16 |
14 |
$53.57 |
| 81003 |
|
29 |
27 |
$49.35 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
174 |
148 |
$49.20 |
| J2920 |
Injection, methylprednisolone sodium succinate, up to 40 mg |
18 |
14 |
$43.40 |
| J1030 |
Injection, methylprednisolone acetate, 40 mg |
16 |
15 |
$40.62 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
95 |
82 |
$17.85 |
| 84145 |
|
13 |
12 |
$3.62 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
30 |
26 |
$1.76 |
| 36415 |
Collection of venous blood by venipuncture |
715 |
611 |
$0.00 |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
308 |
275 |
$0.00 |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
192 |
158 |
$0.00 |
| J2704 |
Injection, propofol, 10 mg |
62 |
43 |
$0.00 |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
20 |
19 |
$0.00 |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
21 |
12 |
$0.00 |
| 96375 |
Therapeutic injection; each additional sequential IV push |
42 |
24 |
$0.00 |